Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays

International Journal of Cancer

Volumn 71, Issue 6, 1997, Pages 1019-1028

  Corey, Eva ^a,b   Wegner, Sandra K ^a   Stray, James E ^a   Corey, Michael J ^a   Arfman, Edward W ^a   Lange, Paul H ^a   Vessella, Robert L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MICE, INBRED BALB C; PROSTATE-SPECIFIC ANTIGEN; SENSITIVITY AND SPECIFICITY;

EID: 0030905740     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970611)71:6<1019::AID-IJC18>3.0.CO;2-8     Document Type: Article

References (24)

1. BUTLER, J.E., JOSHI, S. and BROWN, W.R., The application of traditional immunochemical methods to evaluate the performance of capture antibodies immobilized on microtiter wells. In: J.E. Butler (ed.). Immunochemistry of solid-phase immunoassay, pp. 210-206, CRC Press. Boca Raton, (1991).
2. CHRISTENSSON, A., BJORG, T., NILSSON, O., DAHLEN, U., MATIKAINEN, M.T., COCKETT, A.T., ABRAHAMSSON, P.A. and LILJA, H., Serum prostate- specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 150, 100-105 (1993).
3. DJAVADI-OHANIANCE, L. and FRIGUET, B., The specificity of monoclonal antibodies for enzymes in solution vs. immobilized on solid phases. In: J.E. Butler, (ed.). Immunochemistry of solid-phase immunoassay, pp. 210-206, CRC Press, Boca Raton. (1991).
4. GRAVES, H.C.B., WEHNER, N. and STAMKY, T.A., Comparison of a polyclonal and monoclonal immunoassay for PSA. J. Urol., 144, 1516-1522 (1990).
5. HAAB, F., MEULEMANS, A., RAVERY, V. and BOCCON-GIBOD, L., Prostate specific antigen. Clinical application of ultrasensitive assay. Presse Med. (Paris), 24, 1697-1702 (1995).
6. HARLOW, E. and LANE, D.P., Immunization. In: Antibodies. A laboratory manual, pp. 53-139, Cold Spring Harbor Laboratory. NY (1988).
7. KHOSRAVI, M.J., PAPANASTASIOU-DIAMANDI, A. and MISTRY, J., An ultrasensitive immunoassay for prostate specific antigen based on conventional colorimetric detection. Clin. Biochem., 28, 407-414 (1995).
8. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
9. LILJA, H., CHRISTENSSON, A., DAHLEN, U., MATIKAINEN, M.T., NILSSON, O. and PETTERSSON, K., Prostate specific antigen in serum occurs predominantly in complex with α-1-antichymotrypsin. Clin. Chem., 37, 1618-1625 (1991).
10. MCCORMACK, R.T., RITTENHOUSE, H.G., FINLAY, J.A., SOKOLOFF, R.L., WANG, T.J., WOLFERT, R.L., LILJA, H. and OESTHRLING, J.E., Molecular forms of prostate-specific antigen and human kallikrein gene family: a new era. Urology, 45, 729-744 (1995).
11. ORSTERLING, J.E., Prostate specific antigen: a critical assesment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145, 907-923 (1991).
12. PETTERSSON, K., PIIRONEN, T., SEPPALA, M., LIUKKONEN, L., CHRISTENSSON, A., MATIKAINEN, M.T., SUONPAA, M., LOVGREN, T. and LILJA, H., Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-α-1-antichymotrypsin complex. Clin. Chem.,4, 1480-1488 (1995).
13. PRESTIGIACOMO, A.F. and STAMEY, T.A., A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J. Urol., 152, 1515-1519 (1994).
14. SENSABAUGH, G.F. and BLAKE, E.T., Seminal plasma protein p30: simplified purification and evidence for identity with prostate specific antigen. J. Urol., 144, 1523-1526 (1990).
15. STAMEY, T.A., GRAVES, H.C., WEHNER, N., FERRARI, M. and FREIHA, F.S., Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate-specific antigen. J. Urol., 149, 787-792 (1993).
16. STAMEY, T.A., KABALIN, J.N., MCNEAL, J.E., JOHNSTONE, I.M., FREIHA, F., REDWINE, E.A. and YANG, N., Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. J. Urol., 141, 1076-1083 (1989).
17. STENMAN, U.H., LEINONEN, J., ALFTHAN, H., RANNIKKO, S., TUHKANEN, K. and ALFTHAN, O., A complex between prostate-specific antigen and gamma-1-antichymptrypsin is a major form of prostate-specific antigen in serum of patients with prostatic cancer. Cancer Res., 51, 222-226 (1991).
18. STROBEL, S., SMITH, K., WOLFERT, R. and RITTENHOUSE., H., Role of free PSA discordance across commercial PSA assays. clin. Chem., 42, 645-647 (1996).
19. TAKAYAMA, T.K., VESSELLA, R.L., BRAWER, M.K., NOTEBOOM, J. and LANCE, P.M., The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay. J. Urol., 150, 374-378 (1993).
20. TAKAYAMA, T.K., VESSELLA, R.L. and LANGE, P.H., Newer applications of serum prostate-specific antigen in the management of prostate cancer. Semin. Oncol., 21, 542-553 (1994).
21. VAN DUIJNHOVEN, H.L., PEQUERIAUX, N.C., VAN ZON, J.P. and BLANKEN- STEIN, M.A., Large discrepancy between prostate-specific antigen results from different assays during longitudinal follow-up of a prostate cancer patient. Clin. Chem., 42, 637-641 (1996).
22. WENER, M.H., DAUM, P.R. and BRAWER, M.K., Variation in measurement of prostate specific antigen: importance of method and lot variability. Clin. Chem., 41, 1730-1737 (1995).
23. WILBUR, D.S., Rudiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjugate Chem., 3, 433-470 (1992).
24. Yu, H. and DIAMANDIS, E.P., Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin. Chem., 39, 2108-2114 (1993).